Centaurus Financial »

Cerevel Therapeutics Hldng I shares owned by Centaurus Financial

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Centaurus Financial from 13F filings

Historical chart of Centaurus Financial investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Centaurus Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Centaurus Financial

Quarter filed Position value Share count Share price at filing
2023-12-31 $119k 2.8k 42.50
2022-03-31 $105k 3.0k 35.00

More positions owned by Centaurus Financial

Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Global X Fds Nasdaq 100 Cover (QYLD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Global X Fds S&p 500 Covered (XYLD)
Apple (AAPL)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Floor & Decor Hldgs Cl A (FND)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Select Sector Spdr Tr Technology (XLK)
Alarm Com Hldgs (ALRM)
Microsoft Corporation (MSFT)
Ishares Tr Msci Acwi Etf (ACWI)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)

View all positions for Centaurus Financial

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I